Effect of Exercise Training on Breastmilk Composition
Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Aug 3, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how regular exercise during breastfeeding might change the composition of breastmilk in women who are overweight or obese. Researchers want to find out if these changes in breastmilk can also affect how healthy and how quickly babies grow. The trial is currently looking for women who are 18 years or older, have a body mass index (BMI) indicating they are overweight or obese, have recently given birth to a single baby, and are exclusively breastfeeding.
If you decide to participate, you can expect to engage in an exercise program while continuing to breastfeed your baby. It's important to note that you should not be pregnant again, have certain medical conditions like diabetes or heart disease, or have been exercising intensely before joining. Overall, this study aims to understand the relationship between exercise, breastmilk, and infant health, which could help improve recommendations for new mothers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Aged 18 years or older
- • Body mass index ≥ 25 kg/m2 pre-pregnancy and/or BMI ≥ 28 kg/m2 postpartum
- • Given birth to a singleton term (after 37 weeks + 0 days) baby
- • 6-7 weeks postpartum at time of inclusion
- • Exclusively breastfeeding the baby (no other foods are given) and intend to continue this practice for ≥ 8 weeks at inclusion
- • Understands oral and written Norwegian
- Exclusion Criteria:
- • On-going pregnancy
- • Known type 1 or type 2 diabetes
- • Known cardiovascular disease
- • High intensity exercise more than twice weekly the last three months before inclusion and/or an intention to start regular endurance training within the next 8 weeks at baseline
About Norwegian University Of Science And Technology
The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Patients applied
Trial Officials
Trine Moholdt, PhD
Principal Investigator
Norwegian University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials